Laurie Vaillant
Overview
Explore the profile of Laurie Vaillant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huard A, Fauteux-Daniel S, Goldstein J, Martin P, Jarlborg M, Andries J, et al.
J Immunol
. 2025 Feb;
214(1):180-191.
PMID: 40018678
Interleukin (IL)-18 is an immunoregulatory cytokine that acts as a potent inducer of T helper 1 and cytotoxic responses. IL-18 activity is regulated by its decoy receptor IL-18 binding protein...
2.
Oster P, Vaillant L, McMillan B, Velin D
Front Immunol
. 2022 Jun;
13:899161.
PMID: 35677057
infects the gastric mucosa of a large number of humans. Although asymptomatic in the vast majority of cases, infection can lead to the development of peptic ulcers gastric adenocarcinoma and...
3.
Vaillant L, Oster P, McMillan B, Orozco Fernandez E, Velin D
Helicobacter
. 2022 Jan;
27(2):e12875.
PMID: 35092634
Background: Helicobacter pylori (H. pylori) colonizes the human gastric mucosa with a high worldwide prevalence. Currently, H. pylori is eradicated by the use of antibiotics. However, elevated antibiotic resistance suggests...
4.
Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, et al.
Gut
. 2021 Jul;
71(3):457-466.
PMID: 34253574
Objective: In this study, we determined whether () infection dampens the efficacy of cancer immunotherapies. Design: Using mouse models, we evaluated whether immune checkpoint inhibitors or vaccine-based immunotherapies are effective...
5.
Vaillant L, Oster P, McMillan B, Velin D
Vaccine
. 2021 May;
39(27):3590-3601.
PMID: 34049736
Helicobacter pylori (Hp) colonizes the human gastric mucosa with a high worldwide prevalence. Currently, Hp can be eradicated by the use of antibiotics. Due to the increase of antibiotic resistance,...